CRVS 8-K: SEC filing
Corvus Pharmaceuticals provided a business update and
Filed with the SEC on · accession 0001171843-26-007175
CRVS filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -7.9% by the first close after the filing.
Summary of the filing
Corvus Pharmaceuticals provided a business update and reported Q3 2026 financial results, highlighting progress across its soquelitinib clinical pipeline including Phase 3 PTCL and Phase 2 atopic dermatitis trials, with cash of $202.9 million providing runway into Q2 2028.
Key details
How CRVS stock reacted
Close before
$10.57
Nov 4, 2026
First close after
-7.95%
$9.73
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CRVS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CRVS?
Click hereFrequently asked questions
What did CRVS file with the SEC on Nov 5, 2026?
CRVS filed a 8-K (SEC filing). Corvus Pharmaceuticals provided a business update and reported Q3 2026 financial results, highlighting progress across its soquelitinib clinical pipeline including Phase 3 PTCL and Phase 2 atopic dermatitis trials, with cash of $202.9 million providing runway into Q2 2028.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did CRVS stock react to this filing?
CRVS closed at $10.57 before the filing and $9.73 on Nov 5, 2026 (-7.95%).
Other CRVS SEC filings
Get alerts when CRVS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days